The culture and shipment of islets are an integral part of islet transplant research. Flasks, petri dishes, and bags are the devices used to perform that role. However, these devices have inherent design characteristics that make them poorly suited to the unique needs of islet culture and islet shipping. This results in the use of far too many devices to maintain an islet preparation, a high potential for contamination, severely limited process control, and islet damage during shipping. Unfortunately, little effort has been undertaken to address the problems inherent to existing devices. We propose the creation of a superior device that is ideally suited to oxygenate islets and is tailored to the needs of the islet community. It will be the only device capable of culturing, shipping, and infusing an entire pancreatic islet isolation. This device is referred to as the single layer gas permeable device (SLD). Our investigation is expected to achieve five specific aims.
Aim 1 will define a high-density SLD islet culture protocol that provides islets of superior quality and less immunogenicity than possible with existing devices when an entire islet preparation is cultured in a single device for at least seven-days without feeding. Outcomes will be determined by a variety of techniques including oxygen consumption rate (OCR), OCR/DNA, and molecular profiling.
Aim 2 will adapt the SLD from a culture to a shipping device.
Aim 3 will create a novel gyroscopic shipping container (GSC) that functions as an incubator without need of electronic controls and maintains the SLD in a standing position independent of how its outer container is oriented during shipping. This essentially allows islets to be cultured during shipping.
Aim 4 will verify that the SLD of Aim 2 and the GSC of Aim 3 deliver islet tissue with superior viable islet yield, quality, and reduced immunogenicity relative to existing methods.
Aim 5 will modify the SLD for islet transfusion and verify the superiority of the SLD for islet culture, shipping, and infusion relative to existing methods. Project Narrative: Islet transplants hold promise to provide a better quality of life for those afflicted with diabetes and reduce health care cost to society. There are no cell culture devices on the market that are designed with the attributes needed to efficiently oxygenate islets during culture and shipping. This grant is intended to create a gas permeable device (SLD) that can culture, ship, and infuse islets with maximum efficiency.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44DK069865-04
Application #
7603106
Study Section
Special Emphasis Panel (ZRG1-EMNR-E (10))
Program Officer
Arreaza-Rubin, Guillermo
Project Start
2004-09-30
Project End
2011-03-31
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
4
Fiscal Year
2009
Total Cost
$1,184,237
Indirect Cost
Name
Wilson Wolf Manufacturing Corporation
Department
Type
DUNS #
170969237
City
New Brighton
State
MN
Country
United States
Zip Code
55112
Weegman, Bradley P; Taylor, Michael J; Baicu, Simona C et al. (2016) Plasticity and Aggregation of Juvenile Porcine Islets in Modified Culture: Preliminary Observations. Cell Transplant 25:1763-1775
Kitzmann, J P; Karatzas, T; Mueller, K R et al. (2014) Islet preparation purity is overestimated, and less pure fractions have lower post-culture viability before clinical allotransplantation. Transplant Proc 46:1953-5
Kitzmann, J P; Pepper, A R; Gala-Lopez, B et al. (2014) Human islet viability and function is maintained during high-density shipment in silicone rubber membrane vessels. Transplant Proc 46:1989-91
Abdelli, Saida; Papas, Klearchos K; Mueller, Kate R et al. (2014) Regulation of the JNK3 signaling pathway during islet isolation: JNK3 and c-fos as new markers of islet quality for transplantation. PLoS One 9:e99796
Mueller, Kate R; Balamurugan, A N; Cline, Gary W et al. (2013) Differences in glucose-stimulated insulin secretion in vitro of islets from human, nonhuman primate, and porcine origin. Xenotransplantation 20:75-81
Mueller, Kate R; Martins, Kyra V; Murtaugh, Michael P et al. (2013) Manufacturing porcine islets: culture at 22ýýýýC has no advantage above culture at 37ýýýýC: a gene expression evaluation. Xenotransplantation 20:418-28
Papas, Klearchos K; Karatzas, Theodore; Berney, Thierry et al. (2013) International workshop: islet transplantation without borders enabling islet transplantation in Greece with international collaboration and innovative technology. Clin Transplant 27:E116-25
Weegman, B P; Taylor, M J; Baicu, S C et al. (2012) Hypothermic Perfusion Preservation of Pancreas for Islet Grafts: Validation Using a Split Lobe Porcine Model. Cell Med 2:105-110
Avgoustiniatos, Efstathios S; Scott 3rd, William E; Suszynski, Thomas M et al. (2012) Supplements in human islet culture: human serum albumin is inferior to fetal bovine serum. Cell Transplant 21:2805-14
Suszynski, T M; Avgoustiniatos, E S; Stein, S A et al. (2011) Assessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy. Transplant Proc 43:3221-5